Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 190 | 2022 |
Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin E Oton, R Barcena, JM Moreno-Planas, V Cuervas-Mons, ... American Journal of Transplantation 6 (10), 2348-2355, 2006 | 145 | 2006 |
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry C Stephens, M Robles-Diaz, I Medina-Caliz, M Garcia-Cortes, ... Journal of hepatology 75 (1), 86-97, 2021 | 115 | 2021 |
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry C Fernandez Carrillo, S Lens, E Llop, JM Pascasio, J Crespo, J Arenas, ... Hepatology 65 (6), 1810-1822, 2017 | 107 | 2017 |
Mycophenolate mofetil can be used as monotherapy late after liver transplantation JMM Planas, VCM Martinez, ER Gonzalez, AG Cruz, J Lopez-Monclus, ... American Journal of Transplantation 4 (10), 1650-1655, 2004 | 93 | 2004 |
Role of chemical structures and the 1331T> C bile salt export pump polymorphism in idiosyncratic drug‐induced liver injury E Ulzurrun, C Stephens, E Crespo, F Ruiz‐Cabello, J Ruiz‐Nuñez, ... Liver International 33 (9), 1378-1385, 2013 | 50 | 2013 |
Real-world effectiveness and safety of oral combination antiviral therapy for hepatitis C virus genotype 4 infection J Crespo, JL Calleja, I Fernández, B Sacristan, B Ruiz-Antorán, ... Clinical Gastroenterology and Hepatology 15 (6), 945-949. e1, 2017 | 36 | 2017 |
Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA‐C real‐world cohort M Hernández‐Conde, I Fernández, C Perelló, A Gallego, M Bonacci, ... Journal of viral hepatitis 26 (1), 55-64, 2019 | 28 | 2019 |
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles C Stephens, A Castiella, EM Gomez-Moreno, P Otazua, MÁ López-Nevot, ... Pharmacogenetics and Genomics 26 (9), 414-422, 2016 | 26 | 2016 |
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C J Ampuero, C Jimeno, R Quiles, JM Rosales, S Llerena, N Palomo, ... Journal of hepatology 68 (5), 940-948, 2018 | 17 | 2018 |
Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology E Oton, R Barcena, M Castillo, M Barreales, C Blesa, JM Moreno-Planas, ... Transplantation proceedings 38 (8), 2499-2501, 2006 | 17 | 2006 |
Spanish group for the study of the use of direct-acting drugs hepatitis c collaborating group. Real-world effectiveness and safety of oral combination antiviral therapy for … J Crespo, JL Calleja, I Fernández, B Sacristan, B Ruiz-Antorán, ... Clin Gastroenterol Hepatol 15 (6), 945-949, 2017 | 10 | 2017 |
Fístula broncobiliar entre un quiste hidatídico hepático y el lóbulo medio del pulmón derecho J Moreno Planas, L Abreu García, JC Méndez Cendón, ... Anales de Medicina Interna 19 (12), 39-40, 2002 | 10 | 2002 |
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r±dasabuvir±ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human … J Manuel Sousa, M Vergara, F Pulido, G Sánchez Antolín, L Hijona, ... PloS one 14 (11), e0225061, 2019 | 7 | 2019 |
Hepatotoxicity with autoimmune features. Analysis of the cases included in the Spanish Dili registry A Castiella, E Zapata, MI Lucena, P Otazua, P Martinez-Odriozola, ... BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 109, 53-53, 2011 | 5 | 2011 |
FRI-225-Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection J Cabezas, IF Vázquez, S Llerena, JA Carrion, AG Moya, S Lens, ... Journal of Hepatology 70 (1), e493-e494, 2019 | 4 | 2019 |
Rupture of the spleen following endoscopic retrograde cholangiopancreatography M Cortiñas-Sáenz, G Maldonado-Hermosos, JI Miota-de-Llama, ... Revista Espanola de Enfermedades Digestivas 102 (7), 457, 2010 | 4 | 2010 |
Free transplantation of the finger joints J Planas Rev Esp Cir Plast 1, 12, 1968 | 4 | 1968 |
Hepatitis C virus Core antigen as an alternative to RNA in the assessment of response to treatment with direct-acting Oral antivirals AM Martínez, PN Serrano, JCF de Cañete Camacho, JMM Planas Hepatitis Monthly 21 (9), 2021 | 2 | 2021 |
Effectiveness and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C: results from a Spanish Cohort (Hepa-C) M Puigvehi, A Albillos, A Viu, MN Hernandez Guerra, I Fernandez, ... Hepatology 68, 357A-358A, 2018 | 2 | 2018 |